AnaptysBio Inc buy Guggenheim
Start price
28.05.25
/
50%
€18.40
Target price
28.05.26
€79.52
Performance (%)
106.52%
Price
12.12.25
€38.00
Summary
This prediction is currently active. With a performance of 106.52% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 28.05.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 0.000% | 0.000% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target raised by analysts at Guggenheim from $54.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat